Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Elevated prostate-specific antigen levels in black men and white men

R Sawyer1, J J Berman, A Borkowski

  • 1Department of Surgery, Veterans Affairs Maryland Health Care System, Baltimore 21201, USA.

Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|November 1, 1996
PubMed
Summary

Prostate-specific antigen (PSA) screening ranges, typically based on White men, show significantly higher 95th percentile PSA values in Black men across all age groups. This highlights potential racial disparities in prostate cancer risk assessment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

International Council for Standardization in Haematology (ICSH) recommendations for the performance and interpretation of activated partial thromboplastin time and prothrombin time mixing tests.

International journal of laboratory hematology·2024
Same author

Identification of high thrombotic risk triple-positive antiphospholipid syndrome patients is dependent on anti-cardiolipin and anti-β2glycoprotein I antibody detection assays.

Journal of thrombosis and haemostasis : JTH·2018
Same author

A comparative analysis of different automated von Willebrand factor glycoprotein Ib-binding activity assays in well typed von Willebrand disease patients.

Journal of thrombosis and haemostasis : JTH·2018
Same author

Newly developed dilute Russell's viper venom reagents for lupus anticoagulant detection with improved specificity.

Lupus·2017
Same author

Clinical value of digital image analysis in the diagnosis of urinary bladder cancer, particularly in aggressive tumors: a preliminary report.

Polish journal of pathology : official journal of the Polish Society of Pathologists·2016
Same author

Influence of oligomeric herbicidal ionic liquids with MCPA and Dicamba anions on the community structure of autochthonic bacteria present in agricultural soil.

The Science of the total environment·2016

Area of Science:

  • Urology
  • Public Health
  • Racial Health Disparities

Background:

  • Current prostate-specific antigen (PSA) reference ranges are primarily derived from White populations.
  • These standard ranges are applied universally, assuming minimal clinical significance of racial differences in PSA levels.
  • Emerging evidence suggests PSA levels may correlate with prostate cancer risk within specific racial groups.

Purpose of the Study:

  • To determine and compare 95th percentile PSA ranges in Black and White men.
  • To investigate potential racial variations in PSA levels relevant to prostate cancer screening.
  • To inform the development of more accurate, race-specific PSA screening guidelines.

Main Methods:

  • Analysis of PSA test results from 10,808 men (40+ years) without known prostate cancer at the Veterans Affairs Maryland Health Care System.

Related Experiment Videos

  • Categorization of patients into Black, White (Not of Hispanic Origin), and Other Race/Race Unknown groups.
  • Calculation of 95th percentile PSA values for Black and White men within distinct age brackets (40-49, 50-59, 60-69, 70-79, 80+).

    • Main Results:

    • Black men consistently exhibited higher 95th percentile PSA values than White men across all age groups studied.
    • For men aged 70-79, the 95th percentile PSA was 15.45 ng/mL for Black men versus 9.40 ng/mL for White men (ratio 1.6).
    • The largest absolute and relative differences in PSA ranges were observed in older age cohorts.

    Conclusions:

    • Established PSA screening ranges may underestimate elevated PSA levels in Black men.
    • Race-specific PSA reference ranges are necessary for accurate prostate cancer risk assessment and screening.
    • Clinical guidelines should consider racial differences to improve early detection and reduce disparities in prostate cancer outcomes.